Related Experiment Video
Updated: May 13, 2026

Isolation and Chemical Characterization of Lipid A from Gram-negative Bacteria
Published on: September 16, 2013
Apolipoprotein A-I binding to anionic vesicles and lipopolysaccharides: role for lysine residues in antimicrobial
Wendy H J Beck1, Christopher P Adams, Ivan M Biglang-Awa
1Department of Chemistry and Biochemistry, California State University Long Beach, Long Beach, CA 90840, USA.
Abstract:
Human apolipoprotein A-I (apoA-I) is a 28kDa protein and a major component of high-density lipoproteins, mediating several essential metabolic functions related to heart disease. In the present study the potential protective role against bacterial pathogens was explored. ApoA-I suppressed bacterial growth of Escherichia coli and Klebsiella pneumoniae. The protein was able to bind lipopolysaccharides and showed a strong preference for bilayer vesicles made of phosphatidylglycerol over phosphatidylcholine. Lysine side chains of apoA-I were acetylated to evaluate the importance of electrostatic forces in the binding interaction with both membrane components. Electrophoresis properties, dot blot analysis, circular dichroism, and fluorescence spectroscopy to probe for changes in protein structure indicated that the acetylated protein displayed a strongly reduced lipopolysaccharide and phosphatidylglycerol binding. A mutant containing only the N-terminal domain of apoA-I also showed a reduced ability to interact with the membrane components, although to a lesser extent. These results indicate the potential for apoA-I to function as an antimicrobial protein and exerts this function through lysine residues.
Insights
Human apolipoprotein A-I (apoA-I) shows antimicrobial properties by suppressing bacterial growth. Its function relies on lysine residues for binding to bacterial membrane components like lipopolysaccharides.
Area of Science:
- Biochemistry
- Microbiology
- Cardiovascular Science
Background:
- Human apolipoprotein A-I (apoA-I) is a key component of high-density lipoproteins.
- ApoA-I plays a critical role in lipid metabolism and cardiovascular health.
Purpose of the Study:
- To investigate the potential antimicrobial role of apoA-I against bacterial pathogens.
- To elucidate the mechanism of apoA-I's interaction with bacterial membranes.
Main Methods:
- Bacterial growth suppression assays with Escherichia coli and Klebsiella pneumoniae.
- Lipopolysaccharide (LPS) and lipid bilayer vesicle binding studies.
- Acetylation of apoA-I lysine residues to assess electrostatic interactions.
- Structural analysis using circular dichroism and fluorescence spectroscopy.
Main Results:
- ApoA-I demonstrated significant suppression of E. coli and K. pneumoniae growth.
- ApoA-I preferentially bound to phosphatidylglycerol over phosphatidylcholine vesicles and LPS.
- Acetylation of lysine residues drastically reduced apoA-I binding to LPS and phosphatidylglycerol.
- A truncated apoA-I mutant showed diminished membrane component interaction.
Conclusions:
- ApoA-I possesses antimicrobial activity against Gram-negative bacteria.
- The antimicrobial function is mediated by electrostatic interactions involving lysine residues.
- ApoA-I's interaction with bacterial membranes is crucial for its antibacterial effect.
More Related Videos
10:59Enrichment of Bacterial Lipoproteins and Preparation of N-terminal Lipopeptides for Structural Determination by Mass Spectrometry
Published on: May 21, 2018
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
Related Concept Videos
Formation of Lipopolysaccharides
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Inhibitors of Bacterial Protein Synthesis